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Abstract: 
 
Dementia may be more common in older adults with intellectual disability (ID) than in 
the general population. The increased risk for Alzheimer’s disease in people with 
Down Syndrome (DS) is well established, but much less is known about dementia in 
adults with ID who do not have DS. We estimated  incidence rates from a longitudinal 
study of dementia in older adults with ID without DS and compared them to general 
population rates. 222 participants with ID without DS aged 60 years and older were 
followed up  an average of 2.9 years later to identify those who had declined in  
functional or cognitive abilities. Those who screened positive had a comprehensive 
assessment for dementia, diagnosed using ICD 10 and  DSM IV criteria.  134 
participants who did not have dementia at initial assessment were alive and 
interviewed at follow up; 21 (15.7%) were diagnosed with dementia. Overall 
incidence rate for those aged ≥ 60 was 54.6/ 1000 person years (95% CI 34.1 – 82.3). 
The highest incidence rate (97.8/1000 person years) was in the age group 70-74. 
Standardised incidence ratio for those aged ≥ 65 was 4.98 (95% CI 1.62 – 11.67).  
Incidence of dementia in older people with intellectual disabilities is up to five times 
higher than older adults in the general population.  Screening may be useful in this 
population given the high incident rates, particularly as more effective treatments 
become available. Studies to explore the underlying aetiological factors for dementia 
associated with intellectual disability could help to identify novel protective and risk 
factors.   
 
261 words 
1. Background  
 
There have been several epidemiological studies of dementia in older adults with 
Down Syndrome (DS) which is known to be associated with an increased risk for 
Alzheimer’s Disease (AD), but much less is known about dementia in the Intellectual 
Disability population who do not have Down Syndrome (non-DS ID)(Strydom, 
Shooshtari, et al., 2010).  
 
Dementia may also be more common in adults with non-DS ID compared to the 
general population because of specific risk factors.  ID is by definition associated with 
reduced brain reserve (i.e. smaller brain size, fewer neurons or synapse count) 
(Stern, 2002). The brain reserve hypothesis proposes that there is a critical threshold 
of reserve capacity that needs to be breached by pathological processes before 
clinical or functional symptoms will develop. Those with more reserve have been 
found to be less likely to develop dementia or cognitive decline (Valenzuela & 
Sachdev, 2006; Whalley, Deary, Appleton, & Starr, 2004). The brain reserve 
hypothesis therefore predicts that older adults with ID should have higher rates of 
dementia than those with normal intelligence, and that dementia rates will be 
relatively high in  younger age groups because those with progressive brain 
pathology will quickly reach a functional cut-off with early emergence of symptoms 
(Strydom, Hassiotis, King, & Livingston, 2009). Furthermore, several rare genetic ID 
syndromes are associated with progressive decline. However, older adults with ID 
may also be protected against dementia. For instance, they often have better 
cardiovascular risk profiles such as lower rates of smoking and ischaemic heart 
disease, which may reduce their risk for  dementia, particularly vascular dementia 
(Haveman et al., 2010).   
 
There have been a small number of dementia prevalence studies in the non-DS ID 
population, with several studies (Cooper, 1997; Shooshtari, Martens, Burchill, Dik, & 
Naghipur, 2011; Strydom, Livingston, King, & Hassiotis, 2007) showing an increased 
prevalence while some found rates similar to those in the general population (Zigman 
et al., 2004). We have previously shown that dementia prevalence varies by 
diagnostic criteria used, disability level and age (Strydom et al., 2009, 2007). 
Prevalence is also strongly influenced by mortality rates, and older adults with 
dementia have much higher mortality rates than those without dementia (Rait et al., 
2010). Prevalence rates may therefore underestimate a population’s risk for 
dementia.  
 
The present study reports the annual incidence of dementia in older adults with non-
DS ID and compares it with population rates (standardised incidence ratio, SIR).  
2. Materials and Method 
 
This study reports on follow-up of the BOLD cohort which is described elsewhere  
(Strydom et al., 2009, 2007; Strydom, Romeo, et al., 2010). Appropriate ethics 
approval was obtained. Participants were any adults aged 60 years and older (mean 
age 68.8 years, SD 7.45; range 60 - 94) living in five London boroughs, who had ID 
of any aetiology except DS. ID was defined using ICD-10 criteria for mental 
retardation, and participants were identified by contacting all ID and ageing service 
providers within each borough. 222 participants participated in the baseline study 
(2004 -2005), of whom 33.3% lived independently, in family homes or in settings 
without 24 hour support; 51.8% lived in community settings with 24 hour support, and 
14.9% lived in hospitals or nursing homes. Informants were direct care staff, family or 
befrienders (73.9%), home managers (12.6%), nurses and other professionals (8.1%) 
or day care staff (4.5%).   28  met at least one of ICD-10, DSM-IV or DC-LD sets of 
dementia criteria. Participants were reassessed a mean of 2.9 years later (SD = 0.42; 
34.2 months, range 25 – 45 months)  using  a screen for dementia or cognitive 
decline; interviewers were blind to baseline assessments. Informants needed to have 
known the individual for at least the previous two years. If this was not possible, then 
the informants were asked to consult with others or to refer to case notes and care 
plans before completing the rating. 
Those screened positive had a full diagnostic assessment for dementia.  
2.1. Screening and assessment 
The dementia screening procedure was similar at both time points (T1 and T2). 
Screen positives were those who scored at or above the threshold for dementia for 
severe, mild-moderate and mild ID on the cognitive scale of the Dementia 
Questionnaire for Persons with Mental Retardation (DMR) (Evenhuis, 1996); decline 
in more than three aspects of activities of daily living on an adapted activities of daily 
living (ADL) schedule not accounted for by physical health issues; or a delayed recall 
after ten minutes of fewer than two items in a 3-item memory task based on the Shoe 
Box Test (Burt & Aylward, 2000). Those screening negative were presumed not to 
have dementia.  
 
Informants completed a questionnaire based on the Cambridge Mental Disorders 
Examination (CAMDEX), in order to determine whether participants who screened 
positive had symptoms of dementia (Roth et al., 1986). Participants who were 
sufficiently able also completed cognitive assessments described elsewhere 
(Jamieson-Craig, Scior, Chan, Fenton, & Strydom, 2010; Strydom et al., 2007). 
These included the Test for Severe Impairment (Albert & Cohen, 1992), Mini Mental 
State Examination (Folstein, Robins, & Helzer, 1983) and the Tower of London test  
(Shallice, 1982). A structured physical examination was conducted to record 
neurological symptoms and signs associated with dementia and to identify thyroid 
disorder, stroke, Parkinson’s disease and other physical disorders relevant to the 
differential diagnosis of dementia. 
2.2. Diagnosis 
Diagnostic procedures and reliability and validity of diagnoses are described in detail 
in other reports (Strydom et al., 2012, 2009, 2007). At baseline, independent 
diagnosis of dementia was made by two psychiatrists using an operationalized 
criteria tick list according to international operationalized dementia criteria. 
Disagreements were discussed with a third psychiatrist to reach a consensus 
decision. For the purpose of the incidence study, we defined dementia cases at 
baseline as all the participants who satisfied at least one of these criteria i.e. ICD-10 
(World Health Organization, 1992) , DSM-IV-TR (American Psychiatric Association, 
2000), Dementia with Lewy bodies  (McKeith et al., 2005) and frontotemporal 
dementia criteria (McKhann et al., 2001). All baseline dementia cases were excluded 
from the incidence calculation.  
 
At follow up, ICD10 and DSM IV dementia criteria were used to define cases. 
Independent diagnosis of dementia was once again made by two psychiatrists and 
disagreements were discussed with a third psychiatrist to reach a consensus 
decision. These disagreements as well as the final decision in ratings were recorded 
and subsequent analysis showed that inter-rater reliability was very good or near-
perfect (Strydom et al., 2012). 
2.3. Analysis 
SPSS (v14) was used for this analysis. Incidence rates were calculated per 1000 
person years, with 95% confidence intervals (CI) using binomial statistics. We used 
general population dementia rates from the MRC Cognitive Function and Ageing 
Studies (MRC-CFAS) (Matthews, Brayne, & Medical Research Council Cognitive 
Function and Ageing Study Investigators, 2005) for comparison, as this was the 
largest and most recent  incidence study of dementia in England and allowed 
comparisons by age and sex. The MRC-CFAS included several urban and rural 
locations, and used the Geriatric Mental State/ AGECAT system which allows ICD10, 
DSMIIIR or DSMIV dementia diagnoses. The MRC-CFAS dementia diagnoses were 
equivalent to DSMIIIR diagnoses (Matthews et al, 2005).  
 
Age adjusted rates for those aged 65 and older were provided by the indirect method 
using reference rates in 5 year age bands from the MRC-CFAS and summed to 
calculate an age adjusted standardised incidence ratio (SIR). 95% CI of the SIR was 
calculated using Poisson statistics.  
 
To examine the impact mortality rates may have had on overall incidence rates, we 
conducted a sensitivity analysis by assuming that had all deceased participants lived, 
they would have had the same prevalence of dementia we observed in the baseline 
study stratified by age group (Strydom et al., 2007).  
3. Results 
 
One person was not included in this analysis as we were not able to gain enough 
information at T2 to determine his/her dementia status. 134/ 193 (69%) of those 
without dementia at T1 participated and were included in the T2 incidence analysis; 
29 (15%) had died, and 30 (15.5%) dropped out.  21 (15.7%) new cases of dementia 
was diagnosed at T2 meeting either  ICD 10 (n=14) or DSM IV dementia criteria 
(n=16)  (table 1). There was a trend for those with incident  dementia to be older than 
those without dementia  (72.1 years; sd =  6.3; vs. 69.5 years; sd  = 5.8; t = -1.896; p 
= 0.06) there were no significant differences by sex (χ2 = ; df = 1; p = 0.467) or  
severity of ID  (χ2 = 4.535; df = 2; p = 0.104). 
 
Table 1 shows incident rates by age group and overall rates. In order to allow 
comparison with general population rates from CFAS, the analysis was restricted to 
those aged 65 and over.   The resulting SIR of the observed incidence rates 
compared to the general population rates was 4.98 (95% CI  1.62 – 11.67).  
 
Incidence rates in older people with ID peaked at 70-74 (see table 1).  Overall rates 
for men aged 60 and older was higher than for women, but this difference was not 
significant (men, 64.9 / 1000 person years; 95% CI 35.0 – 108.4 vs. women 43.5/ 
1000 person years; 95% CI 19.0 – 83.9).  
 
Sensitivity analyses did not reveal significant effect of mortality upon overall rates, 
but had the biggest effect on incidence rates in the oldest age groups (see table 1).  
 
[Table 1 near here] 
 
4. Discussion: 
 
We found an incidence of dementia  in adults with ID aged 65 and older which is up 
to five times higher than in the general population. Incidence peaked at age 70-74, in 
contrast to a steady increase in the general population even beyond 90 years 
(Corrada, Brookmeyer, Paganini-Hill, Berlau, & Kawas, 2010).   We did not find 
higher rates in women, which differs from dementia incidence studies in the general 
population (Van der Flier, 2005).  
 
4.1. Strengths and limitations 
We undertook detailed assessments of screen positives and assigned dementia 
status using rigorous diagnostic procedures. We took a conservative approach by 
excluding all dementia cases at baseline (including those who met subtype criteria for 
Lewy body dementia and frontotemporal dementia) while using only DSM IV and 
ICD10 criteria to define incident  cases . However, as no screening strategy for 
dementia in the ID population is completely robust, we may have missed some 
participants with incident dementia; thereby underestimating incidence. Furthermore, 
our previous work has shown diagnostic issues may affect estimates of dementia in 
this population, though these were as likely to result in under, as over, estimates 
(Strydom et al., 2012, 2007). Nevertheless, ICD10 and DSM IV diagnoses showed 
substantial inter-rater reliability (κ > 0.68) and had high specificity (~95%) (Strydom et 
al., 2012).  
 When stratified by age bands or by sex, incidence rates had wide confidence 
intervals and we may therefore have missed smaller age or sex effects, but this 
remains the largest study of dementia incidence in older adults with ID (without Down 
syndrome) to date.  Our findings are in keeping with previously reported increased 
prevalence rates of dementia in older adults with ID, but high mortality rates in older 
adults with ID and dementia could have affected rates as the excess incidence rates 
compared to the general population are even higher than the excess prevalence 
rates (Strydom et al., 2007) suggesting that people with ID and dementia have 
shorter survival than those in the general population.  
 
4.2. Implications 
This study confirms that older adults with non-DS ID are a high risk group for 
dementia. Incidence rates were considerably higher than general population rates, 
but not as high as the rates for people with Down syndrome. The increased risk for 
Alzheimer’s Disease (AD) in Down Syndrome is believed to be due to triplication of 
genes on chromosome 21,  including Amyloid Precursor Protein (APP) gene which is 
strongly implicated in AD (Vilardell et al., 2011). Our results are in keeping with the 
possibility that other genetic factors involved in brain development, learning and 
memory may be associated with neurodegeneration in later life. Recent examples 
include neurodegeneration associated with Kleefstra syndrome (Verhoeven, Egger, 
Vermeulen, Van de Warrenburg, & Kleefstra, 2011), and a mutation affecting 
sodium/proton exchanger SLC9A6 which causes severe ID and tau deposition 
(Garbern et al., 2010), as well as the discovery of a Fragile X-associated 
tremor/ataxia syndrome that often presents with progressive decline (Hagerman & 
Hagerman, 2004). 
 
It is also possible that the increased likelihood to present with symptoms of dementia 
may, at least in part, be related to the reduced brain reserve associated with 
intellectual disability. The brain reserve hypothesis holds that reduced brain reserve  
should increase vulnerability to neuropathology in later life, and our findings are in 
keeping with this hypothesis. There may also be environmental effects that are 
important – many people with ID are not engaged in protective cognitively stimulating 
activities (such as education or meaningful occupation) to the same extent as their 
peers in the general population. Research to identify the underlying aetiology and risk 
factors for dementia in this  population may therefore help to understand the 
aetiology of dementia in general – for example, by contrasting and comparing genetic 
and environmental factors associated with dementia in the Down Syndrome 
population to those in the non-DS ID population. This may reveal important risk and 
protective factors.  
 
Our findings have important clinical implications. Current guidance does not support  
population screening for dementia in the UK or in the USA (National Collaborating 
Centre for Mental Health, 2007; Strydom, Shooshtari, et al., 2010). However, 
screening may be useful in older people with ID (even without DS) given the high 
incidence rates, particularly as their life expectancy increases and more effective 
treatments become available. Lack of recognition may delay provision of extra help 
or result in excess treatment with antipsychotics which increase morbidity and 
mortality (Gill et al., 2007; Treloar et al., 2010). Further research is therefore required 
to develop accurate screening strategies and to explore strategies for early diagnosis 
in this population.  
 
5. Conclusion 
Incidence of Dementia defined with DSMIV or ICD10 criteria is increased in older 
adults with Intellectual disability. Overall incidence rate for those aged ≥ 60 was 54.6/ 
1000 person years (95% CI 34.1 – 82.3) and the standardised incidence ratio for 
those aged ≥ 65 was 4.98 (95% CI 1.62 – 11.67); dementia incidence is thus up to 5 
times higher than in the general population. Mortality-adjusted rates increased from 
24/1000 person-years in those aged 60-64 to 97.8/1000 person-years in those aged 
70-74. There were no gender differences in dementia incidence rates. Screening to 
identify those with cognitive decline may be useful in older people with ID, even those 
without Down Syndrome, particularly as their life expectancy increases and more 
effective treatments become available, and further research is needed to explore 
aetiological factors associated with increased risk for dementia in the non-DS ID 
population. 
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Table 1: Observed and mortality adjusted incidence rates in 5 year age bands  
 
* excluding tentative cases  
 
 
 
 
 
 
 
Age Person years 
of follow-up  
ICD 10 dementia* DSM IV dementia  Any dementia  
  Cases 
(%) 
Rate per 1000 
person years 
(95% CI) 
Cases (%) Rate per 1000 
person years  
(95% CI) 
All Cases 
(%) 
Overall rate 
per 1000 
person years 
(95% CI) 
Mortality adjusted 
rates per 1000 
person years 
(95% CI) 
 
60 - 64 71.8 2 (7.7) 27.9  
(3.4 – 97.0) 
1 (3.8) 13.9  
(0.4 – 75.2) 
 
2 (7.7) 27.9 
(3.4 – 97.0) 
24 
(7.0 – 78.7) 
65 - 69 152.1 3 (5.8) 19.7  
(4.1 – 56.6) 
5 (9.6) 32.9  
(10.8 – 75.0) 
 
5 (9.6) 32.9  
(10.8 – 75.0) 
31.8  
(13.3 – 68.6) 
70 - 74 75.3 5 (19.2) 66.4  
(21.9 – 148.2) 
6 (23.1) 79.6 
(29.8 – 165.4) 
 
9 (34.6) 119.5  
(56.1 – 214.8) 
97.8  
(48.3 – 161.8) 
75 and 
older 
85.2 4 (13.3) 46.9  
(12.9 – 115.9) 
4 (13.3) 46.9  
(12.9 – 115.9) 
 
5 (16.7) 58.2  
(19.3 – 131.7) 
71.0 
(31.5 – 125.3) 
Overall:   
 
Aged 60 
and older 
 
Aged 65 
and older  
 
 
384.3 
 
 
312.5 
 
 
14 
(10.4) 
 
- 
 
 
36.4  
(20.1 – 60.4) 
 
- 
 
 
16 (11.9) 
 
 
- 
 
 
41.6  
(24.0 – 66.7) 
 
- 
 
 
 
21 (15.7) 
 
 
19 (17.3) 
 
 
54.6  
(34.1 – 82.3) 
 
60.8 
(37.0 – 93.3) 
 
 
 
53.7 
(28.0 – 67.7) 
 
60.9 
(41.0 – 89.6) 
